Effect of phacoemulsification on trabeculectomy functio

Not Applicable

Completed

• Conditions: Cataract and glaucoma; Eye Diseases

• Registration Number: ISRCTN91835217
• Lead Sponsor: Sohag University

Brief Summary

2017 results in https://pubmed.ncbi.nlm.nih.gov/28651590/ (added 26/11/2020)

Detailed Description

Not available

Study Timeline

• Study Completion: 2016-01-15
• Study Start: 2017-06-06
• Last Update Posted: 2020-12-07

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

1. Previous successful trabeculectomy not augmented by antimetabolites and had well-controlled IOP
2. Well-functioning bleb, no preoperative glaucoma medications
3. A visually significant cataract before phacoemulsification
4. Aged 18 and older

Exclusion Criteria

1. Patients with primary angle closure glaucoma,
2. Secondary glaucoma
3. Associated eye diseases
4. Preoperative antimetabolite use
5. Posterior capsule rupture and/or vitreous loss during phacoemulsification

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<br> 1. Intraocular pressure changes is measured using the Goldman tonometer … at day one, one week, one month, three months, six months, and one year postoperatively<br> 2. Bleb morphology score is measured using the Wuerzburg bleb classification score at day one, one week, one month, three months, six months, and one year postoperatively<br> 3. Additional glaucoma medications are measured using patient's records up to one year postoperatively<br>

Secondary Outcome Measures

Name	Time	Method
There are no secondary outcome measures.